Psoriasis is a chronic autoimmune disease. In addition to scaly plaques, especially on the elbows, knees, and scalp, it can also cause inflammatory changes in joints, tendons, ligaments, and nails. In severe cases, those affected often feel stigmatized and socially excluded.
In our specialized practice, we can bring psoriasis symptoms to near-complete healing using state-of-the-art therapeutic procedures — so that you can once again feel comfortable in your skin and return to a normal daily life.
These biotechnologically produced substances can intervene in the inflammatory cascade of psoriasis and block the effect of inflammation-promoting molecules. As our understanding of the disease improves, new active substances are continuously being developed, allowing for more precise treatment of psoriasis.
In our practice, we use the following preparations: the TNF alpha blocker adalimumab (Humira); the IL-17 antibodies brodalumab (Kyntheum), secukinumab (Cosentyx), and ixekizumab (Taltz); the IL-12/23 antibody ustekinumab (Stelara); guselkumab (Tremfya), risankizumab (Skyrizi), and tildrakizumab (Ilumetri), which act against IL-23; as well as the PDE-4 inhibitor apremilast (Otezla).
Doctors with Heart and Experience
Modern Dermatology & Aesthetics
Heilwigstraße 33, 20249 Hamburg
